Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-07-01

FDA Approved: ZOLPIDEM TARTRATE — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approves Sandoz Inc's original ANDA for zolpidem tartrate, a generic product for the short-term treatment of insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem Tartrate (zolpidem tartrate)

Snippet

ORIG AP for ZOLPIDEM TARTRATE (ZOLPIDEM TARTRATE)